TTM
-206.2%
YoY change
+167.69pp
Trough year (2020)
-681.8%
Peak year (2019)
-61.5%
Latest annual
-178.4%
Operating Margin history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: -178.4%
Operating Margin change chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: +167.69pp
Operating Margin history table for Tango Therapeutics (TNGX) from 2019 to 2025
| 2025 | -178.4% | +167.69pp | ||
| 2024 | -346.1% | -33.51pp | ||
| 2023 | -312.6% | +134.21pp | ||
| 2022 | -446.8% | -289.69pp | ||
| 2021 | -157.1% | +524.73pp | ||
| 2020 | -681.8% | -620.31pp | ||
| 2019 | -61.5% | — |
- 2025-178.4%+167.69pp
- 2024-346.1%-33.51pp
- 2023-312.6%+134.21pp
- 2022-446.8%-289.69pp
- 2021-157.1%+524.73pp
- 2020-681.8%-620.31pp
- 2019-61.5%—
Operating Margin values are taken from Tango Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Margin at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's latest reported operating margin is -206.2%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Tango Therapeutics (TNGX) operating margin is -178.39% – expanded 167.7 percentage points year-over-year.
The record annual operating margin stands at -61.51%, reached in 2019; the historical low of -681.82% was recorded in 2020.
Tango Therapeutics Operating Margin by Year
Tango Therapeutics Operating Margin 2025: -178.4%
2025's operating margin for Tango Therapeutics came in at -178.39%, expanded 167.7 percentage points from 2024.
Tango Therapeutics Operating Margin 2024: -346.1%
Tango Therapeutics posted operating margin of -346.09% in 2024, contracted 33.5 percentage points from 2023.
Tango Therapeutics Operating Margin 2023: -312.6%
In 2023, Tango Therapeutics reported operating margin of -312.57%, expanded 134.2 percentage points from 2022.
Tango Therapeutics Operating Margin 2022: -446.8%
Tango Therapeutics operating margin in 2022 was -446.79%, contracted 289.7 percentage points from 2021.
Tango Therapeutics Operating Margin 2021: -157.1%
Tango Therapeutics operating margin in 2021 was -157.09%.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Operating Margin
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest operating margin
| 45.9% | |
| 45.3% | |
| 31.6% | |
| 27.6% | |
| 27.6% | |
| 26.4% | |
| 23.7% | |
| 4.2% |
- 45.9%
- 45.3%
- 31.6%
- 27.6%
- 27.6%
- 23.7%
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation